Analyst Price Target is $64.25
▲ +38.59% Upside Potential
This price target is based on 7 analysts offering 12 month price targets for Arcus Biosciences in the last 3 months. The average price target is $64.25, with a high forecast of $100.00 and a low forecast of $51.00. The average price target represents a 38.59% upside from the last price of $46.36.
Current Consensus is
The current consensus among 7 investment analysts is to buy stock in Arcus Biosciences. This Buy consensus rating has held steady for over two years.